Targeting phosphoinositide 3-kinase—Moving towards therapy
Top Cited Papers
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1784 (1) , 159-185
- https://doi.org/10.1016/j.bbapap.2007.10.003
Abstract
No abstract availableKeywords
This publication has 256 references indexed in Scilit:
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- PLA2 and PI3K/PTEN Pathways Act in Parallel to Mediate ChemotaxisDevelopmental Cell, 2007
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaCancer Cell, 2006
- The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 TranslationCell, 2005
- Selective role of PI3Kδ in neutrophil inflammatory responsesBiochemical and Biophysical Research Communications, 2003
- cDNA Cloning of a Third Human C2-Domain-Containing Class II Phosphoinositide 3-Kinase, PI3K-C2γ, and Chromosomal Assignment of This Gene (PIK3C2G) to 12p12Genomics, 1998
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Identification and cDNA Cloning of a Novel Mammalian C2 Domain-Containing Phosphoinositide 3-Kinase, HsC2-PI3KBiochemical and Biophysical Research Communications, 1997
- A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegansNature, 1996